New Warnings for Genentech, OSI Pharmaceuticals, Inc. Tarceva Cancer Drug

May 11, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters -- New warnings have been added to Genentech Inc and OSI Pharmaceutical Inc's cancer drug Tarceva about reports of skin reactions, eye problems and holes in the digestive tract, U.S. health regulators said on Friday.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals

Genentech, Inc.